12:00 AM
 | 
Jun 26, 2000
 |  BC Week In Review  |  Clinical News  |  Clinical Status

BLyS: Began Phase I trial

Human Genome Sciences Inc. (HGSI), Rockville, Md.
Product: BLyS
Business: Autoimmune/Inflammation
Therapeutic category: Immune stimulation
Target:...

Read the full 72 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >